Gradual Occlusion of an Anterior Choroidal Artery Aneurysm Using Overlapping Flow Diversion and Short-term Anticoagulation: A Case Report
Abstract
Anterior choroidal artery aneurysms, in which the anterior choroidal artery arises from the aneurysmal sac, pose significant therapeutic challenges, as treatment risks include branch occlusion and devastating ischemic complications, including hemiplegia and hemianopia. We report a patient in their 70s with an incidentally diagnosed 12.2 mm unruptured right anterior choroidal artery aneurysm, in which three-dimensional angiography demonstrated that the anterior choroidal artery originated from the center of the aneurysm dome. During conservative observation, the aneurysm enlarged to 14.1 mm, necessitating intervention. We employed overlapping flow diverters (2 Pipeline Shield devices) with minimal loose coiling to facilitate controlled thrombosis. To prevent rapid aneurysm thrombosis and subsequent anterior choroidal artery occlusion, we administered modified triple antithrombotic therapy comprising dual antiplatelet agents (prasugrel 3.75 mg and aspirin 100 mg) and reduced-dose rivaroxaban (10 mg daily) for 30 days postoperatively. At 12-month follow-up, angiography demonstrated near-complete aneurysm occlusion (O'Kelly-Marotta grade C3) and a significant reduction in aneurysm size. Critically, during gradual aneurysmal shrinkage, the orifice of the anterior choroidal artery progressively migrated toward the aneurysm neck, allowing branch preservation while the sac underwent organized thrombosis. No perioperative or delayed ischemic complications occurred, and magnetic…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.